Condition: Cervical Cancer · Uterine Cancer · Endometrial Cancer · Sponsor: Abramson Cancer Center at Penn Medicine
This is a single institution, multi-center, Phase II, single-arm study, using Whole Pelvis (WP) Pencil Beam Scanning Proton Radiation (PBS PRT) in the post-surgical, adjuvant setting for definitive treatment of gynecologic cancers. The purpose of this study is to estimate rate of acute clinician-reported gastrointestinal (GI) toxicity using WP PBS PRT in the definitive treatment of gynecologic cancers in the post-surgical, adjuvant setting.
This description comes directly from the study's public registry record.
Project Manager · 215-662-3790 · RadOncCRU@PennMedicine.upenn.edu
Always discuss trial participation with your own doctor first.
| Virtua Health | Voorhees Township, New Jersey, United States | Recruiting |
| Lancaster General Health - Ann B. Barshinger Cancer Institute | Lancaster, Pennsylvania, United States | Recruiting |
| University of Pennsylvania | Philadelphia, Pennsylvania, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05758688